Leave a Reply
You must be logged in to view and post comments.
The United States has mobilized the full force of its clinical research enterprise to address the Covid-19 pandemic, allocating billions of dollars to support timely research. As of January 2021, for example, the National Institutes of Health (NIH) had issued nearly a thousand awards cumulatively worth roughly $2 billion to support Covid-19 projects ranging from the development of medical products (including diagnostics and vaccines) to evaluations of population-specific risk factors and outcomes. Such initiatives, which have yielded new technologies and important evidence, illustrate the value of robust scientific infrastructure.Subscribe to Comments